Prescription opioids among older adults: ten years of data across five countries.
Nordic countries
Older adults
Opioids
Pharmacoepidemiology
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
16 05 2022
16 05 2022
Historique:
received:
26
08
2021
accepted:
09
05
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
20
5
2022
Statut:
epublish
Résumé
Opioid use has increased globally in the recent decade. Although pain remains a significant problem among older adults, susceptibility to opioid-related harms highlights the importance of careful opioid therapy monitoring on individual and societal levels. We aimed to describe the trends of prescription opioid utilisation among residents aged ≥65 in all Nordic countries during 2009-2018. We conducted cross-sectional measurements of opioid utilisation in 2009-2018 from nationwide registers of dispensed drugs in Denmark, Finland, Iceland, Norway, and Sweden. The measures included annual opioid prevalence, defined daily doses (DDDs) per 1000 inhabitants per day (DIDs), and morphine milligram equivalents (MMEs) per user per day. From 2009 to 2018, an average of 808,584 of adults aged ≥65 used opioids yearly in all five countries; an average annual prevalence of 17.0%. During this time period, the prevalence decreased in Denmark, Norway, and Sweden due to declining codeine and/or tramadol use. Iceland had the highest opioid prevalence in 2009 (30.2%), increasing to 31.7% in 2018. In the same period, DIDs decreased in all five countries, and ranged from 28.3 in Finland to 58.5 in Denmark in 2009, and from 23.0 in Finland to 54.6 in Iceland in 2018. MMEs/user/day ranged from 4.4 in Iceland to 19.6 in Denmark in 2009, and from 4.6 in Iceland to 18.8 in Denmark in 2018. In Finland, Norway, and Sweden, MMEs/user/day increased from 2009 to 2018, mainly due to increasing oxycodone utilisation. The stable or decreasing opioid utilisation prevalence among a majority of older adults across the Nordic countries coincides with an increase in treatment intensity in 2009-2018. We found large cross-national differences despite similarities across the countries' cultures and healthcare systems. For the aged population, national efforts should be placed on improving pain management and monitoring future trends of especially oxycodone utilisation.
Sections du résumé
BACKGROUND
Opioid use has increased globally in the recent decade. Although pain remains a significant problem among older adults, susceptibility to opioid-related harms highlights the importance of careful opioid therapy monitoring on individual and societal levels. We aimed to describe the trends of prescription opioid utilisation among residents aged ≥65 in all Nordic countries during 2009-2018.
METHODS
We conducted cross-sectional measurements of opioid utilisation in 2009-2018 from nationwide registers of dispensed drugs in Denmark, Finland, Iceland, Norway, and Sweden. The measures included annual opioid prevalence, defined daily doses (DDDs) per 1000 inhabitants per day (DIDs), and morphine milligram equivalents (MMEs) per user per day.
RESULTS
From 2009 to 2018, an average of 808,584 of adults aged ≥65 used opioids yearly in all five countries; an average annual prevalence of 17.0%. During this time period, the prevalence decreased in Denmark, Norway, and Sweden due to declining codeine and/or tramadol use. Iceland had the highest opioid prevalence in 2009 (30.2%), increasing to 31.7% in 2018. In the same period, DIDs decreased in all five countries, and ranged from 28.3 in Finland to 58.5 in Denmark in 2009, and from 23.0 in Finland to 54.6 in Iceland in 2018. MMEs/user/day ranged from 4.4 in Iceland to 19.6 in Denmark in 2009, and from 4.6 in Iceland to 18.8 in Denmark in 2018. In Finland, Norway, and Sweden, MMEs/user/day increased from 2009 to 2018, mainly due to increasing oxycodone utilisation.
CONCLUSIONS
The stable or decreasing opioid utilisation prevalence among a majority of older adults across the Nordic countries coincides with an increase in treatment intensity in 2009-2018. We found large cross-national differences despite similarities across the countries' cultures and healthcare systems. For the aged population, national efforts should be placed on improving pain management and monitoring future trends of especially oxycodone utilisation.
Identifiants
pubmed: 35578167
doi: 10.1186/s12877-022-03125-0
pii: 10.1186/s12877-022-03125-0
pmc: PMC9112605
doi:
Substances chimiques
Analgesics, Opioid
0
Oxycodone
CD35PMG570
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
429Informations de copyright
© 2022. The Author(s).
Références
Scand J Public Health. 2016 May;44(3):258-63
pubmed: 26647094
Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):301-307
pubmed: 29527817
Eur J Clin Pharmacol. 2021 Apr;77(4):617-624
pubmed: 33112987
Age Ageing. 2011 Jan;40(1):23-9
pubmed: 21068014
J Bone Miner Metab. 2017 May;35(3):289-297
pubmed: 27023332
Pain. 2013 Dec;154 Suppl 1:S94-S100
pubmed: 24036286
J Am Med Dir Assoc. 2018 Apr;19(4):372.e1-372.e8
pubmed: 29402646
Drugs Real World Outcomes. 2019 Dec;6(4):155-164
pubmed: 31535353
J Am Geriatr Soc. 2014 Jun;62(6):1007-16
pubmed: 24823985
Pain. 2013 Dec;154(12):2649-2657
pubmed: 24287107
Eur J Pain. 2009 Oct;13(9):954-62
pubmed: 19091608
Br J Pain. 2022 Feb;16(1):6-13
pubmed: 35111309
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):691-9
pubmed: 23703712
Am J Geriatr Pharmacother. 2010 Jun;8(3):233-44
pubmed: 20624613
Basic Clin Pharmacol Toxicol. 2010 Feb;106(2):86-94
pubmed: 19961477
Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S3-11
pubmed: 16448873
Lakartidningen. 2017 May 2;114:
pubmed: 28485763
Scand J Pain. 2019 Apr 24;19(2):345-353
pubmed: 30677000
Eur J Pain. 2014 Mar;18(3):438-46
pubmed: 23900890
Palliat Med. 2011 Oct;25(7):725-32
pubmed: 21378066
J Med Toxicol. 2012 Dec;8(4):335-40
pubmed: 22992943
Int J Epidemiol. 2016 Oct;45(5):1401-1402g
pubmed: 27892409
Clin Epidemiol. 2014 Jan 08;6:37-48
pubmed: 24470773
Pain Med. 2015 Feb;16(2):319-27
pubmed: 25352175
Eur Spine J. 2016 Sep;25(9):2822-32
pubmed: 26951172
Ann Rheum Dis. 2014 Sep;73(9):1659-64
pubmed: 23744977
Pain Manag Nurs. 2011 Dec;12(4):206-17
pubmed: 22117752
Drugs Aging. 2012 Apr 1;29(4):285-305
pubmed: 22462628
Pharmacotherapy. 2019 Feb;39(2):150-160
pubmed: 30636337
Eur J Pain. 2017 Apr;21(4):658-667
pubmed: 27862681
J Am Med Dir Assoc. 2019 Mar;20(3):305-311
pubmed: 30824218
Addiction. 2021 Jan;116(1):170-175
pubmed: 32267581
Scand J Pain. 2019 Jul 26;19(3):491-499
pubmed: 30817310
Pain Manag. 2016;6(3):249-63
pubmed: 26988312
J Am Geriatr Soc. 2009 Aug;57(8):1331-46
pubmed: 19573219
BMC Health Serv Res. 2017 Sep 19;17(1):668
pubmed: 28927415
Pain. 2017 Feb;158(2):252-260
pubmed: 28092324
Scand J Public Health. 2019 Aug;47(6):611-617
pubmed: 29886814
Drug Alcohol Depend. 2015 Apr 1;149:117-21
pubmed: 25678441
World J Clin Cases. 2017 Mar 16;5(3):73-81
pubmed: 28352631
Cancer J. 2017 Jul/Aug;23(4):242-245
pubmed: 28731948
CMAJ. 2017 May 8;189(18):E659-E666
pubmed: 28483845
Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1403-1410
pubmed: 28895247
Age Ageing. 2013 Mar;42 Suppl 1:i1-57
pubmed: 23420266